How to buy PerkinElmer shares

Own PerkinElmer shares in just a few minutes.

Picture not described

We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!

PerkinElmer, Inc (PKI) is a leading diagnostics & research business with stocks listed in the US. It opened the day at US$146.55 after a previous close of US$146.11. During the day the price has varied from a low of USD145.35 to a high of USD147.18. The latest price was USD146.51 (25 minute delay). PerkinElmer is listed on the NYSE. All prices are listed in US Dollars.

How to buy shares in PerkinElmer

  1. Compare share trading platforms. To buy shares in a US company from Australia you'll need to find a trading platform that offers access to US stock markets. If you're just starting out, look for a platform with low brokerage and foreign exchange fees.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, credit card or debit card.
  3. Search for PerkinElmer. Find the share by name or ticker symbol: PKI. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until PerkinElmer reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of US$138.96, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs. You may be able to buy a fractional share of PerkinElmer, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of PerkinElmer. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

PerkinElmer share price

Use our graph to track the performance of PKI stocks over time.

PerkinElmer shares at a glance

Information last updated 2021-06-11.
OpenUS$146.55
HighUS$147.18
LowUS$145.35
CloseUS$146.51
Previous closeUS$146.11
Change US$0.4
Change % 0.2738%
Volume 285,453
Information last updated 2021-06-10.
52-week rangeUS$92.7267 - US$162.539
50-day moving average US$138.8737
200-day moving average US$138.2821
Target priceUS$158.5
PE ratio 15.2771
Dividend yield US$0.28 (0.2%)
Earnings per share (TTM) US$9.564

Compare share trading platforms to buy stock

Name Product Standard brokerage for US shares Inactivity fee Currency conversion fee Markets
eToro Share Trading (US stocks)
US$0
US$10 per month if there’s been no login for 12 months
0.50%
US shares, ETFs
Zero brokerage share trading on US stocks with trades as low as $50.
Join the world’s biggest social trading network when you trade stocks, commodities and currencies from the one account.
IG Share Trading
Finder Award
IG Share Trading
US$0
$50 per quarter if you make fewer than three trades in that period
0.70%
ASX shares, Global shares
$0 brokerage for US and global shares plus get an active trader discount of $5 commission on Australian shares.
Enjoy some of the lowest brokerage fees on the market when trading Australian shares, international shares, plus get access to 24-hour customer support.
Saxo Capital Markets (Classic account)
US$9.9
No
0.75%
ASX shares, Global shares, Forex, CFDs, Margin trading, Options trading, ETFs
Acess 19,000+ stocks on 37 exchanges worldwide
Low fees for Australian and global share trading, no inactivity fees, low currency conversion fee and optimised for mobile.
CMC Markets Stockbroking
US$0
No
0.60%
ASX shares, Global shares, mFunds, ETFs
$0 brokerage on global shares including US, UK and Japan markets.
Trade up to 9,000 products, including shares, ETFs and managed funds, plus access up to 15 major global and Australian stock exchanges.
loading

Compare up to 4 providers

The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.

Is it a good time to buy PerkinElmer stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

PerkinElmer price performance over time

Historical closes compared with the last close of $146.51

1 week (2021-06-01) 3.35%
1 month (2021-05-11) 5.07%
3 months (2021-03-11) 16.06%
6 months (2020-12-11) 0.30%
1 year (2020-06-11) 51.81%
2 years (2019-06-11) 57.33%
3 years (2018-06-11) 85.57%
5 years (2016-06-10) 172.88%

Is PerkinElmer under- or over-valued?

Valuing PerkinElmer stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of PerkinElmer's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

PerkinElmer's P/E ratio

PerkinElmer's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 15x. In other words, PerkinElmer shares trade at around 15x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

PerkinElmer's PEG ratio

PerkinElmer's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.7545. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into PerkinElmer's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

PerkinElmer's EBITDA

PerkinElmer's EBITDA (earnings before interest, taxes, depreciation and amortisation) is US$1.7 billion.

The EBITDA is a measure of a PerkinElmer's overall financial performance and is widely used to measure a its profitability.

PerkinElmer financials

Revenue TTM US$4.4 billion
Operating margin TTM 32.04%
Gross profit TTM US$2.1 billion
Return on assets TTM 11.73%
Return on equity TTM 31.76%
Profit margin 24.19%
Book value 35.714
Market capitalisation US$16.4 billion

TTM: trailing 12 months

Shorting PerkinElmer shares

There are currently 4.5 million PerkinElmer shares held short by investors – that's known as PerkinElmer's "short interest". This figure is 12.7% up from 4.0 million last month.

There are a few different ways that this level of interest in shorting PerkinElmer shares can be evaluated.

PerkinElmer's "short interest ratio" (SIR)

PerkinElmer's "short interest ratio" (SIR) is the quantity of PerkinElmer shares currently shorted divided by the average quantity of PerkinElmer shares traded daily (recently around 932319.13580247). PerkinElmer's SIR currently stands at 4.86. In other words for every 100,000 PerkinElmer shares traded daily on the market, roughly 4860 shares are currently held short.

However PerkinElmer's short interest can also be evaluated against the total number of PerkinElmer shares, or, against the total number of tradable PerkinElmer shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case PerkinElmer's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 PerkinElmer shares in existence, roughly 40 shares are currently held short) or 0.0518% of the tradable shares (for every 100,000 tradable PerkinElmer shares, roughly 52 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against PerkinElmer.

Find out more about how you can short PerkinElmer stock.

PerkinElmer's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like PerkinElmer.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

PerkinElmer's total ESG risk score

Total ESG risk: 21.66

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and PerkinElmer's overall score of 21.66 (as at 12/31/2018) is pretty good – landing it in it in the 25th percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like PerkinElmer is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

PerkinElmer's environmental score

Environmental score: 3.15/100

PerkinElmer's environmental score of 3.15 puts it squarely in the 4th percentile of companies rated in the same sector. This could suggest that PerkinElmer is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

PerkinElmer's social score

Social score: 12.09/100

PerkinElmer's social score of 12.09 puts it squarely in the 4th percentile of companies rated in the same sector. This could suggest that PerkinElmer is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

PerkinElmer's governance score

Governance score: 9.42/100

PerkinElmer's governance score puts it squarely in the 4th percentile of companies rated in the same sector. That could suggest that PerkinElmer is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

PerkinElmer's controversy score

Controversy score: 2/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. PerkinElmer scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that PerkinElmer has, for the most part, managed to keep its nose clean.

Environmental, social, and governance (ESG) summary

PerkinElmer, Inc was last rated for ESG on: 2019-01-01.

Total ESG score 21.66
Total ESG percentile 24.92
Environmental score 3.15
Environmental score percentile 4
Social score 12.09
Social score percentile 4
Governance score 9.42
Governance score percentile 4
Level of controversy 2

PerkinElmer share dividends

3%

Dividend payout ratio: 3.02% of net profits

Recently PerkinElmer has paid out, on average, around 3.02% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.2% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), PerkinElmer shareholders could enjoy a 0.2% return on their shares, in the form of dividend payments. In PerkinElmer's case, that would currently equate to about $0.28 per share.

While PerkinElmer's payout ratio might seem low, this can signify that PerkinElmer is investing more in its future growth.

PerkinElmer's most recent dividend payout was on 5 August 2021. The latest dividend was paid out to all shareholders who bought their shares by 14 July 2021 (the "ex-dividend date").

Have PerkinElmer's shares ever split?

PerkinElmer's shares were split on a 2:1 basis on 3 June 2001. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your PerkinElmer shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for PerkinElmer shares which in turn could have impacted PerkinElmer's share price.

PerkinElmer share price volatility

Over the last 12 months, PerkinElmer's shares have ranged in value from as little as US$92.7267 up to US$162.539. A popular way to gauge a stock's volatility is its "beta".

PKI.US volatility(beta: 1.11)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while PerkinElmer's is 1.1082. This would suggest that PerkinElmer's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

PerkinElmer overview

PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. The company operates in two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detection and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as laboratory services. It also provides analytical technologies, solutions, and services for the environmental, food, and industrial markets that enable its customers to understand the characterization and health of various aspects, including air, water, and soil. In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology and drug discovery. The company serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. PerkinElmer, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.

Frequently asked questions

Ask an Expert

You are about to post a question on finder.com.au:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com.au is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder only provides general advice and factual information, so consider your own circumstances, or seek advice before you decide to act on our content. By submitting a question, you're accepting our Terms of Use, Disclaimer & Privacy Policy and Privacy & Cookies Policy.
Go to site
Not sure what platform to go with?
Take this quick quiz to find the right share trading platform